CEI
ANIK icon

Clark Estates Inc’s Anika Therapeutics ANIK Stock Holding History

Clark Estates Inc’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-63,500
Closed -$2.1M – 112
2015
Q2 		$2.1M Hold
63,500
– – 0.34% 84
2015
Q1 		$2.61M Hold
63,500
– – 0.42% 68
2014
Q4 		$2.59M Buy
63,500
+5,500
+9% +$215K 0.39% 68
2014
Q3 		$2.13M Buy
+58,000
New +$2.51M 0.34% 70

Other funds holding ANIK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
LCP
Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Clark Estates Inc's ANIK Position: Q3 2015 in Review

Clark Estates Inc sold out of Anika Therapeutics (ANIK) in Q3 2015, closing a stake of 63,500 shares — an estimated $2.1M sold.

Clark Estates Inc first reported a position in ANIK in Q3 2014 and held it in 4 quarters. The position peaked at $2.61M in Q1 2015. 138 funds tracked by Wall St. Rank hold ANIK as of Q3 2015.

  • Clark Estates Inc reported no remaining Anika Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Clark Estates Inc sold 63,500 Anika Therapeutics shares in Q3 2015, an estimated $2.1M.
  • Clark Estates Inc first reported a position in Anika Therapeutics in Q3 2014 and held it in 4 quarters.
  • Clark Estates Inc's Anika Therapeutics position peaked at $2.61M in Q1 2015.
  • 138 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2015.

Based on Clark Estates Inc's 13F filing for Q3 2015, filed 6 Nov 2015.